Skip to main content

Advertisement

Table 1 Comparison of the mean levels of s-IgA and s-amylase with oral/dental manifestations among the three studied groups

From: Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes

Oral/dental manifestations s-IgA s-Amylase
uncontrolled diabetic controlled diabetic control p-value uncontrolled diabetic controlled diabetic control p-value
Oral candidiasis 195.79 ± 17.78 98.13 ± 10.67* 107.52 ± 32.69 0.002 193,364.67 ± 36,135.98 48,719.37 ± 28372* 42,078.33 ± 30,461.78 0.018
White plaque 210.76 ± 13.12 81.83 ± 22.68 0.013 307,490 ± 175,903.1 17,760.5 ± 1239.5 0.292
Erythematous candidiasis 209.88 ± 49.64 110.26 ± 23.2 0.436 216,400 ± 23,950.4 25,150 ± 2361.5 0.038
Thrush 221.85 ± 33.63 73.35 ± 6.73* 172.85 ± 8.3 0.57 136,500 ± 26,513.61 138,037 ± 108,821 12,035 ± 8651 0.254
Median rhomboid glossitis 163.13 ± 50.12 121.48 ± 16.93 74.85 ± 2.24 0.215 93,200 ± 37,900 17,670 ± 3452.91 57,100 ± 18,338.8 0.257
abscesses 221.98 ± 39.76 77.84 ± 23.19 0.022 284,466.66 ± 76,543.8 100,500 ± 53,700 0.243 0.243
Xerostomia 205.7 ± 20.87 81.75 ± 12.1* 118.49 ± 33.96 0.0001 189,807.6 ± 44,143.3 59,417.2 ± 2463.08 77,973.3 ± 26,897.8 0.065
  1. s-IgA, salivary immunoglobulin A; s-amylase, salivary amylase. * Significant difference with uncontrolled diabetes (P<0.05). Significant at <0.05 levels